echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Cell Host and Micro: Immune globulin IgA or a special microbiome that can target the body of an inflammatory enteropath!

    Cell Host and Micro: Immune globulin IgA or a special microbiome that can target the body of an inflammatory enteropath!

    • Last Update: 2021-01-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    January 7, 2021 // -- In a recent study published in the international journal Cell Host and Microbe entitled "Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease", scientists from Brown University and others in the United States have found that immunoglobulin A may target a specific microbiome substation in inflammatory bowel disease.
    pathogenesis of inflammatory bowel disease (IBD, inflammatory bowel disease) is thought to be the result of a combination of host genetic factors and intestinal ecological imbalances, and previous studies of a small number of IBD patients have shown that inflammatory bacterial groups tend to be highly covered by the secretional immunoglobulin IgA.
    Photo Source: pasmov.com In this study, researchers used bacterial fluorescence-activated cell sequencing technology in conjunction with 16S rRNA gene sequencing technology (IgA-SEQ) to analyze IGA coverage of gut microbes in the body of a larger queue of IBD patients, while also identifying specific bacteria associated with disease and therapy.
    researchers found that 43 bacterial groups showed significantly higher levels of IGA coverage compared to the controls, eight of which showed different IgA coverage, but with similar abundance.
    Compared to the control group, patients treated with anti-TNF-α therapy tended to exhibit significantly altered microbial-specific IgA responses;
    addition, the research highlights of this paper include: 1) the researchers used IGA-SEQ technology to evaluate a large number of IBD patients with IgA-covered bacterial community; IBD-related bacterial community; 3) patients treated with anti-INF-α therapy were able to exhibit a specific IgA response to microbial changes; and 4) IgA-covered envelopes of bacteria belonging to the genus Vibrillobacteria were directly related to delays in surgery time in IBD patients.
    () Original source: Jason M. Shapiro, Marcel R.de Zoete, Noah W.Palm, et al. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease, Cell Host & Microbe (2020) doi:10.1016/j.chom.2020.12.003
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.